CORE--TECHNOLOGIES FOR RECOMBINANT PROTEINS AND ASSAY REAGENTS

Information

• Research Project
• 2339247

• ApplicationId

  2339247

• Core Project Number

  U19CA067861

• Full Project Number

  5U19CA067861-02

• Serial Number

  67861

• FOA Number

• Sub Project Id

  9001

• Project Start Date

  -

• Project End Date

  -

• Program Officer Name

• Budget Start Date

  10/1/1995 - 30 years ago

• Budget End Date

  9/30/1996 - 29 years ago

• Fiscal Year

  1996

• Support Year

  2

• Suffix

• Award Notice Date

  -

Organizations

• PHARMAGENICS, INC.

The Molecular Biology Core Facility is responsible for supplying all reagents necessary to each of the ELISA-based screens, protein crystallization and structure-activity studies of lead compounds directed toward the biochemical mechanism of action of lead candidates. These reagents include recombinant purified proteins, oligonucleotides, and monoclonal/polyclonal antibodies. The core facility has established the necessary technology and the expertise to efficiently supply these reagents.

IC Name

• Activity

  U19

• Administering IC

  CA

• Application Type

  5

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

• Ed Inst. Type

• Funding ICs

• Funding Mechanism

• Study Section

• Study Section Name

• Organization Name

  PHARMAGENICS, INC.

• Organization Department

• Organization DUNS

• Organization City

  ALLENDALE

• Organization State

  NJ

• Organization Country

  UNITED STATES

• Organization Zip Code

  07401

• Organization District

  UNITED STATES